Journal of Food and Nutrition Research
ISSN (Print): 2333-1119 ISSN (Online): 2333-1240 Website: https://www.sciepub.com/journal/jfnr Editor-in-chief: Prabhat Kumar Mandal
Open Access
Journal Browser
Go
Journal of Food and Nutrition Research. 2023, 11(7), 513-518
DOI: 10.12691/jfnr-11-7-8
Open AccessArticle

Pachypodol, a Plant Flavonoid, Mitigates Cisplatin-induced Hepatotoxicity Through Anti-Oxidant, Anti-Inflammatory and Anti-Apoptotic Mechanisms

Muhammad Umar Ijaz1, Rabia Azmat1, Derya Karataş Yeni2, Asma Ashraf3, and Vanitha Mariappan4,

1Department of Zoology, Wildlife and Fisheries, University of Agriculture, Faisalabad, Pakistan

2Department of Microbiology, University of Necmettin Erbakan, Konya, Turkey

3Department of Zoology, Government College, University, Faisalabad, Pakistan

4Center for Toxicology and Health Risk Studies (CORE), Faculty of Health Sciences, Universiti

Pub. Date: August 11, 2023

Cite this paper:
Muhammad Umar Ijaz, Rabia Azmat, Derya Karataş Yeni, Asma Ashraf and Vanitha Mariappan. Pachypodol, a Plant Flavonoid, Mitigates Cisplatin-induced Hepatotoxicity Through Anti-Oxidant, Anti-Inflammatory and Anti-Apoptotic Mechanisms. Journal of Food and Nutrition Research. 2023; 11(7):513-518. doi: 10.12691/jfnr-11-7-8

Abstract

Cisplatin (CP), a widely used chemotherapeutic drug for cancer treatment is associated with multiple toxicities that limit its clinical application. Pogostemon cablin (Blanco) Benth contains pachypodol, a flavonoid with tremendous bioactive properties. The recent study intended to determine the mitigative role of pachypodol against cisplatin-instigated hepatic damage in albino rats. In this research, 32 albino rats were segregated into four groups (n = 8/group) and treated for 28 consecutive days; 1st group was designed as control, rats of the 2nd group received 10 mg/kg of CP; rats of the 3rd group were co-administered with 10 mg/kg of CP + 20 mg/kg of pachypodol, and 4th group rats received 20 mg/kg of pachypodol. Our results disclosed that CP exposure resulted in a substantial decrease in the activities of antioxidant enzymes i.e., catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione reductase (GSR), glutathione (GSH), and glutathione S-transferase (GST) as well as a notable rise in malondialdehyde (MDA) and reactive oxygen species (ROS) levels. CP exposure escalated levels of nuclear factor kappa B (NF-κB), interleukin-1β (IL-1β), tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and cyclooxygenase-2 (COX-2) activity. Conversely, it diminished anti-apoptotic protein (Bcl-2) levels and elevated pro-apoptotic markers (Bax, caspase-9 and caspase-3). Besides, histopathological analysis revealed evident morphological alterations in the rats' livers. However, pachypodol significantly abated all the liver damage prompted by CP in rats. Taken together, our findings suggested that pachypodol alleviated cisplatin-induced hepatic impairment by inhibiting oxidative stress, inflammation and apoptosis.

Keywords:
Pachypodol Oxidative stress Hepatotoxicity Cisplatin

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Zhou, J., Kang, Y., Chen, L., Wang, H., Liu, J., Zeng, S., Yu, L., “The drug-resistance mechanisms of five platinum-based antitumor agents,” Frontiers in Pharmacology, 11, 343. 2020.
 
[2]  Cavaletti, G., Marmiroli, P., “Chemotherapy-induced peripheral neurotoxicity. Nature Reviews Neurology, 6, 657-66, 2010.
 
[3]  Zhou, J., Nie, R.C., Yin, Y.X., Cai, X.X., Xie, D., Cai, M. Y., “Protective Effect of Natural Antioxidants on Reducing Cisplatin-Induced Nephrotoxicity,” Disease Markers, 2022, 17. 2022.
 
[4]  Kazak, F., Akalın, P.P., Yarım, G.F., Başpınar, N., Özdemir, Ö., Ateş, M.B., “Deveci, M.Z.Y., Protective effects of nobiletin on cisplatin induced neurotoxicity in rats,” International Journal of Neuroscience, 132, 531-537. 2022.
 
[5]  Toplu, Y., Sapmaz, E., Parlakpinar, H., Kelles, M., Kalcioglu MT, Tanbek K and Kizilay A., “The effect of dexpanthenol on ototoxicity induced by cisplatin,” Clinical and Experimental Otorhinolaryngology, 9, 14-20. 2016.
 
[6]  Cagin, Y.F., Atayan, Y., Sahin, N., Parlakpinar, H., Polat, A., Vardi, N., Tagluk, M.E., Tanbek, K., Yildiz, A., “Beneficial effects of dexpanthenol on mesenteric ischemia and reperfusion injury in experimental rat model,” Free Radical Research, 50, 354-365. 2016.
 
[7]  Karale, S., Kamath, J.V., “Effect of daidzein on cisplatin-induced hematotoxicity and hepatotoxicity in experimental rats,” Indian Journal of Pharmacology, 49, 49-54. 2017. 10.4103/0253-7613.201022.
 
[8]  Natarajan, A., Jayavelu, A., Thangamani, R., Prabakarakrishnan, R., Choi, D., Mohammed, A.A., Kumar, B.S., “In vivo evaluation of protective effect of Sargassum fusiforme on cisplatin induced hepato-renal toxicity,” Physiological and Molecular Plant Pathology, 117, 101748. 2022.
 
[9]  Quintanilha, J.C.F., de Sousa, V.M., Visacri, M.B., Amaral, L.S., Santos, R.M.M., Zambrano, T., Salazar, L.A. and Moriel, P., “Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity,” Cancer chemotherapy and pharmacology, 80, 223-233. 2017.
 
[10]  Ahmadipour, F., Sharififar, F., Nakhaipour, M., Samanian, S., Mohajeri, k., “Hepatoprotective effect of Zataria multiflora Boisson cisplatin-induced oxidative stress in male rat,” Journal of Medicine and Life, 8, 275-281. 2015.
 
[11]  Galadari, S., Rahman, A., Pallichankandy, S., Thayyullathil. F., “Reactive oxygen species and cancer paradox: To promote or to suppress,” Free Radical Biology and Medicine, 104, 144-164. 2017.
 
[12]  Davis, C.A., Nick, H.S., Agarwal, A., “Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide,” Clinical Journal of the American Society of Nephrology, 12, 2683-2690. 2001.
 
[13]  Walker, E.H., Pacold, M.E., Perisic, O., Stephens, L., Hawkins, P.T., Wymann, M.P., Williams, R.L., “Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine,” Molecular Cell, 6, 909-19. 2000.
 
[14]  Kim, E.K., Kim, J.H., Jeong, S., Choi, Y.W., Choi, H.J., Kim, C.Y., Kim, Y.M., “Pachypodol, a methoxyflavonoid isolated from Pogostemon cablin bentham exerts antioxidant and cytoprotective effects in HepG2 cells: Possible role of ERK-dependent Nrf2 activation,” International Journal of Molecular Sciences, 20, 4082. 2019,
 
[15]  Lu, T.C., Liao, J.C., Huang, T.H., Lin, Y.C., Liu, C.Y., Chiu, Y.J., Peng, W.H., “Analgesic and anti-inflammatory activities of the methanol extract from Pogostemon cablin,” Evidence-Based Complementary and Alternative Medicine, 2011, 671741. 2011. 10.1093/ecam/nep183.
 
[16]  Park, S.Y., Neupane, G.P., Lee, S.O., Lee, J.S., Kim, M.Y., Kim, S.Y., Park, B.C., Park, Y.J., Kim, J.A., “Protective effects of Pogostemon cablin Bentham water extract on inflammatory cytokine expression in TNBS-induced colitis in rats,” Archives of Pharmacal Research, 37, 253-262. 2014. 10.1007/s12272-013-0260-x.
 
[17]  Kim, H.W., Cho, S.J., Kim, B.Y., Cho, S.I., Kim, Y.K., “Pogostemon cablin as ROS scavenger in oxidant-induced cell death of human neuroglioma cells,” Evidence-Based Complementary and Alternative Medicine, 7, 239-247. 2010. 10.1093/ecam/nem176.
 
[18]  Liu, X.R., Fan, R., Zhang, Y.Y., Zhu, M.J., “Study on antimicrobial activities of extracts from Pogestemon cablin (Blanco) Benth.,” Food Science & Technology, 24, 220-227. 2009.
 
[19]  Aebi, Hugo. "13 Catalase in vitro." Methods in enzymology. Academic press, 105. 1984, 121-126.
 
[20]  Kakkar, P., Das, B., Viswanathan, P.N., “A modified spectrophotometric assay of superoxide dismutase,” Indian Journal of Biochemistry and Biophysics, 21, 130-132. 1984.
 
[21]  Moron, M.J., Diperre, J.W., Mannerv, K.B., “Levels of glutathione, glutathione reductase and glutathione-s-transferase activities in rat lungs and liver,” Biochimica et Biophysica Acta, 582, 67-71. 1979.
 
[22]  Rotruck, J.T., Pope, A.L., Ganther, H.E., Swanson, A.B., Hafeman, D.G., Hoekstra, W.G., “Selenium: biochemical role as a component of glutathione peroxidase” Science, 179, 588-590. 1973.
 
[23]  Younis, T., Khan, M.R., Sajid, M., “Protective effects of Fraxinus xanthoxyloides (wall.) leaves against CCl4 induced hepatic toxicity in rat,” BMC Complementary and Alternative Medicine, 16, 407-420. 2016.
 
[24]  Carlberg, I., Mannervik, E., “Glutathione level in rat brain,” Journal of Biological Chemistry, 250, 4475-4480. 1975.
 
[25]  Ohkawa, H., Ohishi, N., Yagi, K., “Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, 95, 351-358. 1979.
 
[26]  Hayashi, I., Morishita, Y., Imai, K., Nakamura, M., Nakachi, K., Hayashi, T., “High-throughput spectrophotometric assay of reactive oxygen species in serum,” Mutation Research: Genetic Toxicology and Environmental Mutagenesis, 631, 55-61. 2007.
 
[27]  Hassan, S.M., Saeed, A.K., Rahim, O.O., Mahmood, SA., “Alleviation of cisplatin-induced hepatotoxicity and nephrotoxicity by L-carnitine,” Iranian Journal of Basic Medical Sciences, Sci. 25, 897. 2022. 10.22038/IJBMS.2022.65427.14395.
 
[28]  Abd Rashid, N., Abd Halim, S.A.S., Teoh, S.L., Budin, S.B., Hussan, F., Ridzuan, N.R.A., Jalil, N.A.A., “The role of natural antioxidants in cisplatin-induced hepatotoxicity. Biomedicine & Pharmacotherapy, 144, 112328. 2021.
 
[29]  Aitken, R.J., Roman, S.D., “Antioxidant systems and oxidative stress in the testes,” Oxidative Medicine and Cellular Longevity, 1, 15-24. 2008.
 
[30]  Liochev, S.I., Fridovich, I., “Mechanism of the peroxidase activity of Cu, Zn superoxide dismutase,” Free Radical Biology and Medicine, 48, 1565-1569. 2010.
 
[31]  Fenoglio, C., Boncompagni, E., Fasola, M., Gandini, C., Comizzoli, S., Milanesi, G., Barni, S., “Effects of environmental pollution on the liver parenchymal cells and Kupffer-melanomacrophagic cells of the frog Rana esculenta,” Ecotoxicology and Environmental Safety, 60, 259-268. 2005.
 
[32]  Hayes, J.D., Flanagan, J.U., Jowsey, I.R., “Glutathione transferases,” Annual review of pharmacology and toxicology, 45, 51-88. 2005.
 
[33]  Ahmad, A., Rasheed, N., Chand, K., Maurya, R., Banu, N., Palit, G., “Restraint stress-induced central monoaminergic & oxidative changes in rats & their prevention by novel Ocimum sanctum compounds,” Indian Journal of Medical Research, 135, 548. 2012.
 
[34]  Temel, Y., Kucukler, S., Yıldırım, S., Caglayan, C., Kandemir, F.M., “Protective effect of chrysin on cyclophosphamide-induced hepatotoxicity and nephrotoxicity via the inhibition of oxidative stress, inflammation, and apoptosis,” Naunyn-Schmiedeberg's Archives of Pharmacology, 393, 325-337. 2020.
 
[35]  Gandhi, J., Khera, L., Gaur, N., Paul, C., Kaul, R., “Role of modulator of inflammation cyclooxygenase-2 in gammaherpesvirus mediated tumorigenesis,” Frontiers in Microbiology, 8, 538. 2017.
 
[36]  Indran, I.R., Tufo, G., Pervaiz, S., Brenner, C., “Recent advances in apoptosis, mitochondria and drug resistance in cancer cells,” Biochimica et Biophysica Acta, 1807, 735-745. 2011.
 
[37]  Ramesh, G., Reeves, W.B., “p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice,” American Journal of Physiology-Renal Physiology, 289, F166-F174. 2005.
 
[38]  Han, F., Le, Z., Yu, M., Qi, Z., “In vivo and in vitro study on hepatotoxicity of Tris-(2, 3-dibromopropyl) isocyanurate exposure via mitochondrial and death receptor pathway,” Ecotoxicology and Environmental Safety, 246, 114186. 2022.
 
[39]  Tong, X., Lin, S., Fujii, M., Hou, D.-X., “Molecular mechanisms of echinocystic acid-induced apoptosis in HepG2 cells,” Biochemical and Biophysical Research Communications, 321, 539-546. 2004.
 
[40]  Ezz-Din, D., Gabry, M.S., Farrag, A.R.H., Abdel Moneim, A.E. Physiological and histological impact of Azadirachta indica (neem) leaves extract in a rat model of cisplatin-induced hepato and nephrotoxicity,” Journal of Medicinal Plants Research, 5, 5499-5506. 2011.